Stephen J. Kent

27.2k total citations · 6 hit papers
379 papers, 16.2k citations indexed

About

Stephen J. Kent is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Stephen J. Kent has authored 379 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Immunology, 190 papers in Virology and 106 papers in Epidemiology. Recurrent topics in Stephen J. Kent's work include HIV Research and Treatment (188 papers), Immune Cell Function and Interaction (160 papers) and T-cell and B-cell Immunology (90 papers). Stephen J. Kent is often cited by papers focused on HIV Research and Treatment (188 papers), Immune Cell Function and Interaction (160 papers) and T-cell and B-cell Immunology (90 papers). Stephen J. Kent collaborates with scholars based in Australia, United States and United Kingdom. Stephen J. Kent's co-authors include Adam K. Wheatley, Miles P. Davenport, Jennifer A. Juno, Deborah Cromer, Robert De Rose, Arnold Reynaldi, David S. Khoury, Kanta Subbarao, Ivan Stratov and Timothy E. Schlub and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Stephen J. Kent

370 papers receiving 16.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

2021 2.1k citations David S. Khoury, Deborah Cromer et al. profile →
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

2022 584 citations Chansavath Phetsouphanh, D.R. Darley et al. Nature Immunology profile →
Minimum information reporting in bio–nano experimental literature

2018 482 citations Matthew Faria, Kristofer J. Thurecht et al. profile →
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

2020 411 citations Wen Shi Lee, Adam K. Wheatley et al. Nature Microbiology profile →
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases

2021 187 citations Emily H. Pilkington, Adam K. Wheatley et al. profile →
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection

2023 72 citations David S. Khoury, Timothy E. Schlub et al. profile →

Peers

Countries citing papers authored by Stephen J. Kent

Since Specialization

Citations

This map shows the geographic impact of Stephen J. Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Kent more than expected).

Fields of papers citing papers by Stephen J. Kent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Kent. The network helps show where Stephen J. Kent may publish in the future.

Co-authorship network of co-authors of Stephen J. Kent

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Kent. A scholar is included among the top collaborators of Stephen J. Kent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Kent. Stephen J. Kent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deconvoluting TCR-dependent and -independent activation is vital for reliable Ag-specific CD4 ⁺ T cell characterization by AIM assay 2025 ·Science Advances ·(unknown), (unknown), Hyon‐Xhi Tan, Mai-Chi Trieu, Hyun Jae Lee, (unknown), Ashraful Haque, Stephen J. Kent, Adam K. Wheatley, Jennifer A. Juno	3
2	Performance of Oak Ridge National Laboratory spallation neutron source proton power upgrade cavities and cryomodule production 2024 ·Physical Review Accelerators and Beams ·Pashupati Dhakal, Edward Daly, (unknown), M. Drury, (unknown), D. Forehand, (unknown), (unknown), Stephen J. Kent, (unknown), M. McCaughan, (unknown), A. C. Mitchell, (unknown), M. Stirbet, Kathleen Wilson, (unknown), M. Howell, Sang-Ho Kim, J. Mammosser	0
3	Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery 2024 ·International Journal of Pharmaceutics ·(unknown), Emily H. Pilkington, Yi Ju, Stephen J. Kent, Colin W. Pouton, Nghia P. Truong	6
4	Patient-Specific Nanoparticle Targeting in Human Leukemia Blood 2024 ·ACS Nano ·Yi Ju, Shiyao Li, (unknown), Emily H. Pilkington, (unknown), Magdalena Plebanski, Jiwei Cui, Frank Caruso, Kristofer J. Thurecht, Constantine S. Tam, Stephen J. Kent	19
5	Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin 2024 ·Nature Microbiology ·(unknown), (unknown), Malet Aban, Michelle Wille, Natalie Spirason, Yi‐Mo Deng, Michael A. Carlock, Ted M. Ross, Jennifer A. Juno, Steve Rockman, Adam K. Wheatley, Stephen J. Kent, Ian Barr, David J. Price, Marios Koutsakos	9
6	Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants 2023 ·Medical Microbiology and Immunology ·Ebene R. Haycroft, Samantha K. Davis, (unknown), Ester López, (unknown), Li Lynn Tan, Phillip Pymm, Bruce D. Wines, P. Mark Hogarth, Adam K. Wheatley, Jennifer A. Juno, Samuel J. Redmond, Nicholas A. Gherardin, Dale I. Godfrey, Wai‐Hong Tham, Kevin J. Selva, Stephen J. Kent, Amy W. Chung	9
7	Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions 2023 ·European Journal of Immunology ·(unknown), Kathleen M. Wragg, Wen Shi Lee, Marc Rigau, Adam P. Uldrich, Stephen J. Kent, Jennifer A. Juno	1
8	Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysis 2023 ·medRxiv ·(unknown), Shanchita R. Khan, Eva Stadler, Timothy E. Schlub, Deborah Cromer, Mark N. Polizzotto, Stephen J. Kent, Tari Turner, Miles P. Davenport, David S. Khoury	1
9	Circulating effector γδ T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals 2023 ·Immunology and Cell Biology ·Anouk von Borstel, Thi H. O. Nguyen, Louise C. Rowntree, Thomas M. Ashhurst, Lilith F. Allen, Lauren J. Howson, Natasha E. Holmes, Olivia Smibert, Jason A. Trubiano, Claire L. Gordon, Allen Cheng, Stephen J. Kent, Jamie Rossjohn, Katherine Kedzierska, Martin S. Davey	6
10	Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection breakdown → 2022 ·Nature Immunology ·Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson, Annett Howe, C. Mee Ling Munier, Sheila K. Patel, Jennifer A. Juno, Louise M. Burrell, Stephen J. Kent, Gregory J. Dore, Anthony D. Kelleher, Gail Matthews	584
11	CD73+ CD127high Long-Term Memory CD4 T Cells Are Highly Proliferative in Response to Recall Antigens and Are Early Targets in HIV-1 Infection 2021 ·International Journal of Molecular Sciences ·Nabila Seddiki, John Zaunders, Chansavath Phetsouphanh, Vedran Brezar, Yin Xu, Helen M. McGuire, Michelle Bailey, (unknown), (unknown), C. Mee Ling Munier, Laura Cook, Stephen J. Kent, Andrew R. Lloyd, Barbara Cameron, Barbara Fazekas de St Groth, Kersten K. Koelsch, Mark Danta, Hakim Hocini, Yves Lévy, Anthony D. Kelleher	4
12	Stealth nanorods via the aqueous living crystallisation-driven self-assembly of poly(2-oxazoline)s 2021 ·Chemical Science ·John R. Finnegan, Emily H. Pilkington, Karen Alt, Md. Arifur Rahim, Stephen J. Kent, Thomas P. Davis, Kristian Kempe	46
13	Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting 2020 ·ACS Nano ·Amal J. Sivaram, Andri Wardiana, Sheilajen Alcântara, Stefan Sonderegger, Nicholas L. Fletcher, Zachary H. Houston, Christopher B. Howard, Stephen M. Mahler, Cameron Alexander, Stephen J. Kent, Craig A. Bell, Kristofer J. Thurecht	36
14	Link between Low-Fouling and Stealth: A Whole Blood Biomolecular Corona and Cellular Association Analysis on Nanoengineered Particles 2019 ·ACS Nano ·Alessia C. G. Weiss, Hannah G. Kelly, Matthew Faria, Quinn A. Besford, Adam K. Wheatley, Ching‐Seng Ang, Edmund J. Crampin, Frank Caruso, Stephen J. Kent	53
15	Differential Roles of Plasma Protein Corona on Immune Cell Association and Cytokine Secretion of Oligomeric and Fibrillar Beta-Amyloid 2019 ·Biomacromolecules ·Ava Faridi, Wen Yang, Hannah G. Kelly, Chuanyu Wang, Pouya Faridi, Anthony W. Purcell, Thomas P. Davis, Pengyu Chen, Stephen J. Kent, Pu Chun Ke	14
16	Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults 2017 ·Vaccine ·Fernanda Ana‐Sosa‐Batiz, Angus P. R. Johnston, P. Mark Hogarth, Bruce D. Wines, Ian Barr, Adam K. Wheatley, Stephen J. Kent	16
17	Fc functional antibodies in humans with severe H7N9 and seasonal influenza 2017 ·JCI Insight ·Hillary A. Vanderven, Lu Liu, Fernanda Ana‐Sosa‐Batiz, Thi H. O. Nguyen, Yanmin Wan, Bruce D. Wines, P. Mark Hogarth, Danielle Tilmanis, Arnold Reynaldi, Matthew S. Parsons, Aeron C. Hurt, Miles P. Davenport, Tom Kotsimbos, Allen Cheng, Katherine Kedzierska, Xiaoyan Zhang, Jianqing Xu, Stephen J. Kent	40
18	Long-lived epithelial immunity by tissue-resident memory T (T _RM ) cells in the absence of persisting local antigen presentation 2012 ·Proceedings of the National Academy of Sciences ·Laura K. Mackay, Angus T. Stock, Z. Joel, Claerwen M. Jones, Stephen J. Kent, Scott N. Mueller, William R. Heath, Francis R. Carbone, Thomas Gebhardt	475
19	Robust NK Cell-Mediated Human Immunodeficiency Virus (HIV)-Specific Antibody-Dependent Responses in HIV-Infected Subjects 2008 ·Journal of Virology ·Ivan Stratov, Amy W. Chung, Stephen J. Kent	83
20	Virus-Specific T-Cell Immunity Correlates with Control of GB Virus B Infection in Marmosets 2007 ·Journal of Virology ·David J. Woollard, Gholamreza Haqshenas, Xuebin Dong, Bridget Pratt, Stephen J. Kent, Eric J. Gowans	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact